Indaptus Therapeutics (INDP) Share-based Compensation (2020 - 2026)
Indaptus Therapeutics (INDP) posted Share-based Compensation of -$64,283 for Q2 2026, compared with $180,763 a year earlier.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Share-based Compensation (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Indaptus Therapeutics was $494,274, down 57.8% year-over-year; for FY2024, it was $2.31 million, down 22.3% from FY2023.
- Annual Share-based Compensation shows a four-year compound annual growth rate of 101.5% (FY2020 to FY2024).
- In prior years, Indaptus Therapeutics' Share-based Compensation was $2.97 million in FY2023 (+0.3%), $2.96 million in FY2022 (+95.8%), $1.51 million in FY2021 (+979.1%) and $139,960 in FY2020.
- The Q2 2026 figure stands as the lowest quarterly Share-based Compensation since Q3 2020.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2023, with growth of 31.0%; the weakest was Q2 2025, with a decline of 76.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Indaptus Therapeutics | 210.93 Mn | 183.54 Mn | - | -64,283.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -64,283.00 |
| Mar 31, 2026 | 227,180.00 |
| Sep 30, 2025 | 150,614.00 |
| Jun 30, 2025 | 180,763.00 |
| Mar 31, 2025 | 240,891.00 |
| Dec 31, 2024 | 304,122.00 |
| Sep 30, 2024 | 444,184.00 |
| Jun 30, 2024 | 782,852.00 |
| Mar 31, 2024 | 774,691.00 |
| Dec 31, 2023 | 745,525.00 |
| Sep 30, 2023 | 764,803.00 |
| Jun 30, 2023 | 728,466.00 |
| Mar 31, 2023 | 727,144.00 |
| Dec 31, 2022 | 637,630.00 |
| Sep 30, 2022 | 584,041.00 |
| Jun 30, 2022 | 904,395.00 |
| Mar 31, 2022 | 831,183.00 |
| Dec 31, 2021 | 673,802.00 |
| Sep 30, 2021 | 795,338.00 |
| Jun 30, 2021 | 20,673.00 |
API Access
Indaptus Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();